Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianweitai vs Tamsulosin in BPH
NCT07134907Phase 4Completed
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of silodosin in benign prostatic hyperplasia (BPH), sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Jul 2022; status: completed.
02
Drugs
silodosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT07134907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07134907.